Works by Ping YAN


Results: 3084
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    The impact of COVID-19 pandemic on the health-seeking behaviour of an Asian population with acute respiratory infections in a densely populated community.

    Published in:
    2021
    By:
    • Hwee Mian Jane Tan;
    • Mui Suan Tan;
    • Zi Ying Chang;
    • Kee Tung Tan;
    • Chee Chin David Ng;
    • Ying Khee William Hwang;
    • Yi Ling Eileen Koh;
    • Yan Ping Sarah Low;
    • Ngiap Chuan Tan;
    • Tan, Hwee Mian Jane;
    • Tan, Mui Suan;
    • Chang, Zi Ying;
    • Tan, Kee Tung;
    • Ee, Guan Liang Adrian;
    • Ng, Chee Chin David;
    • Hwang, Ying Khee William;
    • Koh, Yi Ling Eileen;
    • Low, Yan Ping Sarah;
    • Tan, Ngiap Chuan
    Publication type:
    journal article
    15
    16
    17
    18
    19

    Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy aloneIdentification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone

    Published in:
    2015
    By:
    • Yu-Pei Chen;
    • Wen-Na Zhang;
    • Ling-Long Tang;
    • Yan-Ping Mao;
    • Xu Liu;
    • Lei Chen;
    • Guan-Qun Zhou;
    • Hai-Qiang Mai;
    • Jian-Yong Shao;
    • Wei-Hua Jia;
    • Tie-Bang Kang;
    • Mu-Sheng Zeng;
    • Ying Sun;
    • Jun Ma;
    • Chen, Yu-Pei;
    • Zhang, Wen-Na;
    • Tang, Ling-Long;
    • Mao, Yan-Ping;
    • Liu, Xu;
    • Chen, Lei
    Publication type:
    journal article
    20
    21
    22
    23
    24
    25

    Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 18, p. 1589, doi. 10.1001/jama.2025.1132
    By:
    • Liang, Ye-Lin;
    • Liu, Xu;
    • Shen, Liang-Fang;
    • Hu, Guang-Yuan;
    • Zou, Guo-Rong;
    • Zhang, Ning;
    • Chen, Chuan-Ben;
    • Chen, Xiao-Zhong;
    • Zhu, Xiao-Dong;
    • Yuan, Ya-Wei;
    • Yang, Kun-Yu;
    • Jin, Feng;
    • Hu, Wei-Han;
    • Xie, Fang-Yun;
    • Huang, Ying;
    • Han, Fei;
    • Tang, Ling-Long;
    • Mao, Yan-Ping;
    • Lu, Li-Xia;
    • Sun, Rui
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32

    Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial.

    Published in:
    CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 3, p. 203, doi. 10.3322/caac.21881
    By:
    • Tang, Ling‐Long;
    • Chen, Lin;
    • Xu, Gui‐Qiong;
    • Zhang, Ning;
    • Huang, Cheng‐Long;
    • Li, Wen‐Fei;
    • Mao, Yan‐Ping;
    • Zhou, Guan‐Qun;
    • Lei, Feng;
    • Chen, Lu‐Si;
    • Huang, Shao Hui;
    • Chen, Lei;
    • Chen, Yu‐Pei;
    • Zhang, Yuan;
    • Liu, Xu;
    • Xu, Cheng;
    • Zhao, Yin;
    • Li, Ji‐Bin;
    • Liu, Na;
    • Xie, Fang‐Yun
    Publication type:
    Article
    33

    Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter Trial.

    Published in:
    Clinical & Translational Gastroenterology, 2023, v. 14, n. 7, p. e00602, doi. 10.14309/ctg.0000000000000602
    By:
    • Tan, Nian-di;
    • Miao, Xin-pu;
    • Liao, Ai-jun;
    • Liu, Cheng-xia;
    • Wu, Hao;
    • Chen, Hong-hui;
    • Li, Fang-fang;
    • Guo, Qing-hong;
    • Li, Sheng-bao;
    • Tang, Yan-ping;
    • Xia, Min;
    • Liu, You-li;
    • Li, Xing;
    • Chen, Hui-xin;
    • Liu, Xiao-wei;
    • Zhang, Yan;
    • Zhang, Zhen-yu;
    • Chen, Min-hu;
    • Xiao, Ying-lian
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    47
    48
    49
    50